Generics - Dr Reddy's Laboratories

Filter

Current filters:

Dr Reddy's Laboratories

Popular Filters

1 to 25 of 32 results

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Teva and Dr Reddy’s latest to launch generic Lunesta in USA

16-04-2014

Two more companies have debuted generic versions of the insomnia drug Lunesta (eszopiclone) tablets,…

Dainippon Sumitomo PharmaDr Reddy's LaboratoriesGenericsLunestaMarkets & MarketingNeurologicalNorth AmericaSunovion PharmaceuticalsTeva Pharmaceutical IndustriesUSA

Dr Reddy’s sees generics soar due to limited competition

Dr Reddy’s sees generics soar due to limited competition

11-02-2014

India’s second-largest drugmaker Dr Reddy's Laboratories has reported strong third quarter sales of…

Dr Reddy's LaboratoriesFinancialGenericsIndiaPharmaceutical

Dr Reddy's 1st-qtr misses expectations

31-07-2013

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) has posted its unaudited consolidated…

Dr Reddy's LaboratoriesFinancialGenerics

Leading Indian drugmakers eye pharma production in Russia

08-07-2013

Several top Indian drugmakers and suppliers, including Dr Reddy's (NYSE: RDY), Ranbaxy (BSE: 500359),…

Asia-PacificAurobindo PharmaCiplaDr Reddy's LaboratoriesEuropeGenericsProductionRanbaxy Laboratories

Generic launches by Mylan, Stada Arz and Dr Reddy's

27-06-2013

US copy drugs maker Mylan (NYSE: MYL) has launched norethindrone tablets USP, 0.35 the generic version…

Dr Reddy's LaboratoriesEuropeGenericsLamictal XRMarkets & MarketingMen's HealthMicronorMylan LaboratoriesNeurologicalNorth AmericaReproductiveSTADA ArzneimittelViagra

Fujifilm and Dr Reddy's abandon plans for generics JV in Japan

04-06-2013

Japan's Fujifilm Corp and Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) have decided to terminate…

Dr Reddy's LaboratoriesFujifilmGenericsMergers & AcquisitionsProduction

Dr Reddy's 2012 revenues grew 20%, with earnings up 24%

14-05-2013

Dr Reddy's Laboratories (NYSE: RDY), India's second largest drugmaker, has announced its audited consolidated…

Dr Reddy's LaboratoriesFinancialGenerics

News briefs: Dr Reddy's launches generic Accutane; Cyprus drug shortages

29-03-2013

Indian drugmaker Dr Reddy's Laboratories (NYSE: RDY) says it launched Zenatane (isotretinoin capsules…

AccutaneDermatologicalsDr Reddy's LaboratoriesEuropeGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalZenatane

Dr Reddy's in $22.5 million settlement with Nordion

24-03-2013

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) said last Friday (March 22) that…

Dr Reddy's LaboratoriesFinancialGenericsLegalNordion

Watson Pharma now trading as Actavis; Dr Reddy's debuts generic Clarinex Reditabs in USA

28-01-2013

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) announced last week that the company has adopted…

ActavisClarinex ReditabsDr Reddy's LaboratoriesFinancialGenericsManagementMarkets & MarketingWatson Pharmaceuticals

Dr Reddy's beats forecasts with 27% revenue growth and 47% EBITDA rise

31-10-2012

India's second largest drugmaker by sales, Dr Reddy's Laboratories (NYSE: RDY), yesterday announced its…

Dr Reddy's LaboratoriesFinancialGenerics

India's Dr Reddy's to acquire OctoPlus for $35.7 million

22-10-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) announced this morning that it intendeds…

Dr Reddy's LaboratoriesGenericsMergers & AcquisitionsOctoPlusPharmaceutical

"Sandoz will be the leading biosimilars company in 2012," says Visiongain

04-10-2012

Sandoz, the generics unit of Swiss drug major Novartis (NVN: VX), will retain its position as the global…

BiotechnologyDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingNovartisSandoz

Dr Reddy's posts 28% revenue growth for fiscal 1st-qtr 2013

20-07-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) yesterday released unaudited consolidated…

Dr Reddy's LaboratoriesFinancialGenerics

Merck KGaA collaborates with Dr Reddy's on biosimilars

07-06-2012

With the aim of capitalizing on the batch of patent expires for blockbuster biotechnology-based drugs…

BiotechnologyDr Reddy's LaboratoriesGenericsMarkets & MarketingMerck KGaAMerck SeronoOncologyResearch

US FDA approves generic versions of blood thinner Plavix

18-05-2012

Coinciding with the loss of patent protection on Sanofi (Euronext: SAN) and Bristol-Myers Squibb's (NYSE:…

Cardio-vascularClopidogrelDr Reddy's LaboratoriesGenericsMylan LaboratoriesNorth AmericaPlavixRegulation

Dr Reddy's sees FY2011/12 sales rise 30%

14-05-2012

India's second-largest drugmaker, Dr Reddy's Laboratories (NYSE: RDY) posted full year ended March 31,…

Dr Reddy's LaboratoriesFinancialGenerics

1 to 25 of 32 results

Back to top